İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2025

Epidemiology of ventilator associated events in intubated patients: a multicenter observational study

BMC Infectious Diseases

YÖKSİS OpenAlex Açık erişim · gold SJR Q1 JCR Q2 Atıf 2 Yüzdelik 82.5% FWCI 1.49
Yıl
2025
ISSN
1471-2334
Tür
article

Veri kaynağı ayrımı

  • YÖKSİS YÖKSİS makale kaydı
  • OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

İngilizce (OpenAlex)

BACKGROUND: Ventilator-associated infectious complications are the most prevalent healthcare-acquired infection in intensive care units. The surveillance of ventilator-associated events (VAE) has now supplanted traditional ventilator-associated pneumonia (VAP) monitoring. However, its use is not common and limited reports have been published. We aimed to describe the epidemiology, etiology and the prognosis of VAE. METHODS: This multicenter observational-descriptive study was conducted at 15 centers with active prospective surveillance of VAE. Their daily basis follow-up was for 90 days. The Centers for Disease Control and Prevention guideline 2015 update was used for the definition of VAE. VAE subdiagnosis was defined as ventilator-associated condition (VAC), infection-related ventilator-associated complication plus (IVAC-plus), infection-related ventilator-associated complications (IVAC), and possible ventilator-associated pneumonia (PVAP) RESULTS: A total of 185 VAE episodes developed in 174 of the 1018 patients included in the study. The VAE incidences per 1000 mechanical ventilation day were; VAC 2.33, IVAC-plus 6.0, IVAC 1.3 and PVAP 4.7. Additionally 158 VAP episodes (14.8%, 7.09/1000 MV days) were observed, 85 (45.9%, 4.99/1000 MV days) of them fit the definition of a concurrent VAE criteria. Risk factors for VAE included a Sequential Organ Failure Assessment (SOFA) score greater than 7 on admission (odds ratio [OR]: 1.75; 95% confidence interval [CI]: 1.23-2.47), the presence of a tracheostomy (OR:1.78; CI:1.19-2.65), and antibiotic use within the previous 90 days (OR:2.41; CI:1.09-4.20) were risk factors for VAE. The mortality rate was 59.6% in ventilated patients. Multivariate analysis identified several risk factors for mortality, as follows: age greater than 63 years (OR: 1.75; CI: 1.26-2.42), a SOFA score greater than 5 on admission (OR: 2.00; CI: 1.47-1.46), a higher mean Charlson Comorbidity Index (OR: 1.08; CI: 1.02-1.13), being a medical-type patient (OR: 1.54; CI: 1.06-2.21), healthcare-associated infections (OR: 2.01; CI: 1.39-2.88), and the occurrence of VAE (OR: 2.21; CI: 1.04-4.70). CONCLUSION: VAE is a common complication in intubated patients and is 2.21 times more likely to occur in intubated patients who die. Patients with a high SOFA score, tracheostomy and antibiotic use in the last 90 days are at increased risk. prevention of VAE in intubated patients is important for patient survival.

Konular

  • Nosocomial Infections in ICU
  • Infection Control in Healthcare
  • Surgical site infection prevention

Birincil konu Nosocomial Infections in ICU

Yazarlar

  1. ESMA ERYILMAZ EREN
  2. DUYGU MERT
  3. FATMA ESER ANKARA YILDIRIM BEYAZIT ÜNİVERSİTESİ
  4. SENİHA ŞENBAYRAK
  5. GAMZE KALIN ÜNÜVAR
  6. GÜLDEN ESER KARLIDAĞ
  7. TUĞÇE ŞİMŞEK BOZOK
  8. FATMA YEKTA ÜRKMEZ
  9. TUBA İLGAR
  10. CANAN DEMİR
  11. SEÇİL DENİZ
  12. DERYA ÖZYİĞİTOĞLU
  13. NEFİSE ÖZTOPRAK ÇUVALCI
  14. ŞAFAK KAYA
  15. MELTEM ARZU YETKİN GİRESUN ÜNİVERSİTESİ
  16. YOLANDA YOLANDA PENA-LOPEZ
  17. JORDI RELLO
  18. EMİNE ALP MEŞE
  19. ALİ AYDIN ALTUNKAN MERSİN ÜNİVERSİTESİ
  20. KORAY ALTUN BURSA TEKNİK ÜNİVERSİTESİ